semaglutide

weight loss scale weigh measure tape obesity overweight
Biotech

Pfizer’s new prize Metsera touts 14% weight loss for GLP-1

The drug at the center of Pfizer’s buyout has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability.”
James Waldron Sep 30, 2025 6:40am
weight loss scale weigh measure tape obesity overweight

Lilly rounds out orforglipron data ahead of obesity filings

Sep 17, 2025 9:00am
head to head against clash football helmets fight combat

BrightGene tops Novo drug in diabetes ahead of Zepbound showdown

Jun 23, 2025 2:30pm
Eli Lilly

Lilly's oral GLP-1 delivers Ozempic-like efficacy in phase 3

Apr 17, 2025 6:45am
obesity overweight weight loss weigh

Novo links CagriSema to 16% weight loss, sending stock down

Mar 10, 2025 9:30am
finance numbers tape money

Novo stock crashes after CagriSema misses weight-loss goal

Dec 20, 2024 8:15am